Gilead and Kite Oncology Demonstrate Transformative Impact of Cell Therapy and Promise of Blood Cancer Portfolio at ASH 2022 Pharmaceutical Investing
Allergan Aesthetics Reaffirms Commitment to Breast Health Advocacy with Yearlong Program for Breast Cancer Awareness Pharmaceutical Investing
Kura Oncology Announces Financing Transactions with Bristol Myers Squibb and Hercules Capital, Providing Access to up to $150 Million Pharmaceutical Investing
Aurinia Reports Third Quarter and Nine Months 2022 Financial and Operational Results Pharmaceutical Investing
Jounce Therapeutics earns clinical milestone payment under the CCR8 exclusive license agreement with Gilead Sciences, Inc. Pharmaceutical Investing
U.S. Food and Drug Administration Approves Vemlidy® for Treatment of Chronic Hepatitis B Virus Infection in Pediatric Patients Pharmaceutical Investing
Data Reinforcing Impact of Bristol Myers Squibb Cardiovascular Portfolio to be Presented at American Heart Association Scientific Sessions 2022 Pharmaceutical Investing
